Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04992546 · COMPLETED
Trial details
- NCT number
- NCT04992546
- Sponsor
- Principia Biopharma, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2022-12-28
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.